Skip to content

Retrospective study of criteria for sentinel lymph node biopsy in breast cancer

Retrospective study of criteria for sentinel lymph node biopsy in breast cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400081871
Enrollment
Unknown
Registered
2024-03-14
Start date
2022-01-20
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Interventions

Gold Standard:1. Dual tracing method+intraoperative palpation 2. Radioisotope dual-tracer method (radioisotope value)
Index test:1. Dual tracing method 2. Different cutoff value of radioisotopes

Sponsors

West China Hospitalof Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
19 Years to 80 Years

Inclusion criteria

Inclusion criteria: Age>18 years old; Women; The pathological diagnosis was breast cancer after operation; Hormone receptor ER and/or PR positive or negative, HER2 positive or negative (IHC/FISH test), all stages of breast cancer patients; Simultaneously providing complete clinical information for formula analysis and calculation: The main content is as follows: (1) Population statistics: name, age, height, weight (2) Disease information: tumor size and staging, axillary lymph node status, lymph node size, immunohistochemistry results, pathological grade, etc (3) Treatment: surgical time, surgical method, tumor bed count, etc (4) Result: Blue stained lymphatic vessels, blue stained lymph nodes, nuclide count, sentinel lymph node location, etc

Exclusion criteria

Exclusion criteria: (1) Patients undergoing neoadjuvant chemotherapy (2) Pregnant and lactating patients (3) Individuals who have not undergone sentinel lymph node biopsy (4) Incomplete or obvious errors in the recording information of lymph node data (5) History of other malignant tumors (6) Patient refuses to participate in the study

Design outcomes

Primary

MeasureTime frame
Number, the false negative rate , and false positive rate of intraoperatively palpable SLNs;Sensitivity and specificity of intraoperatively palpable SLNs;

Secondary

MeasureTime frame
Sensitivity and specificity of different cutoff value of radioisotopes;False negative rates of SLNB;

Countries

China

Contacts

Public ContactLv Qing

West China Hospital of Sichuan University

lvqing@wchscu.cn+86 189 8060 1462

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026